Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease Fox RJ; Bethoux F; Goldman MD; Cohen JACleve Clin J Med 2006[Jan]; 73 (1): 91-102Recent advances in our understanding of the diagnosis, imaging, pathology, and clinical monitoring of multiple sclerosis (MS) have significantly increased our ability to successfully treat this often perplexing neurologic disorder. Magnetic resonance imaging (MRI) is now integral to the diagnostic process. Treatment of MS can be considered as three parallel pathways: treatment of relapses, symptom management, and long-term prevention of tissue injury.|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/adverse effects/therapeutic use[MESH]|Antineoplastic Agents/adverse effects/therapeutic use[MESH]|Disease Progression[MESH]|Glatiramer Acetate[MESH]|Glucocorticoids/adverse effects/therapeutic use[MESH]|Humans[MESH]|Integrin alpha4[MESH]|Interferon-beta/adverse effects/therapeutic use[MESH]|Magnetic Resonance Imaging[MESH]|Mitoxantrone/adverse effects/therapeutic use[MESH]|Multiple Sclerosis, Relapsing-Remitting/diagnosis[MESH]|Multiple Sclerosis/*diagnosis/*drug therapy/pathology/physiopathology[MESH]|Natalizumab[MESH]|Peptides/adverse effects/therapeutic use[MESH]|Time Factors[MESH] |